Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of Qingfeng Ganke granules for postinfectious cough
ChiCTR-TRC-13003337Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2013
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Qingfeng Ganke in postinfectious cough (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Decrease in cough symptom score. Started Aug 2013; status: completed.
02
Drugs
Qingfeng Ganke
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on ChiCTR-TRC-13003337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003337.